In February, notable health tech companies secured substantial funding, reflecting the sector's growth. OpenEvidence raised $75 million in Series A funding to improve its AI-driven decision-support for doctors, now helping over 10,000 care centers. Abridge, with $250 million in Series D funding, aims to enhance its AI platform that transforms medical conversations into billable documentation, demonstrating its expansive use across multiple medical settings. Lastly, Candid Health's $52.5 million Series C funding will focus on simplifying medical billing through increased automation and efficiency in claims processing.
OpenEvidence secures $75 million to enhance AI in healthcare, aiming to train advanced medical models and grow a specialized team.
Abridge raises $250 million for its AI platform that converts medical conversations into useful documentation, enhancing billing processes.
Candid Health's Series C funding of $52.5 million will further its mission to simplify medical billing and improve claim processing efficiency.
Collection
[
|
...
]